Life Sciences

Life Sciences Law360 provides breaking legal news and analysis on the pharmaceutical and medical device industry. Coverage includes high-stakes litigation and policy developments that affect life sciences companies, as well as licensing deals, mergers, and other corporate transactions.



Sign up for a 7-day FREE trial today!



Latest News in Life Sciences

  • January 23, 2018

    High Court Considers Upending Patent Damages

    The U.S. Supreme Court recently granted certiorari in WesternGeco v. Ion, a case that could have significant ramifications for U.S. patent holders who compete in foreign markets, say attorneys with MoloLamken LLP.

  • January 22, 2018

    IP Owners Group Says USPTO Fees Rule Is ‘Crippling’

    The IP Owners Association says a new rule by the United States Patent and Trademark Office requiring applicants that appeal its decisions to pay the agency’s legal bills creates a "crippling" burden, according to an amicus brief unsealed Monday at the Federal Circuit.

  • January 22, 2018

    Fed. Circ. Bats Down Helsinn Bid To Stay On-Sale Bar Ruling

    The Federal Circuit on Monday rejected Helsinn Healthcare’s request to stay its ruling invalidating four patents related to an anti-nausea drug while the company seeks to put its case before the U.S. Supreme Court, saying the decision was narrowly tailored and Helsinn didn’t show it faces irreparable injury.

  • January 22, 2018

    Fenwick IP Partner Tapped As Calif. Fed. Magistrate Judge

    A Palo Alto-based Fenwick & West LLP partner with experience handling intellectual property litigation for clients in the technology and life sciences industries has been chosen to fill a magistrate judgeship in the Northern District of California, the court said Monday.

  • January 22, 2018

    Express Scripts Beats Pharmacy's Antitrust Suit

    A Missouri federal judge on Monday ended a suit claiming that Express Scripts Inc. illegally kicked a pharmacy out of its network, finding there wasn’t evidence the benefits manager had anti-competitive motivations for determining the pharmacy violated the terms of their contract.

See more Life Sciences news

Life Sciences

Areas of Coverage

  • AGENCIES
  • U.S. Consumer Product Safety Commission
  • U.S. Food and Drug Administration
  • U.S. Patent and Trademark Office
  • U.S. International Trade Commission
  • POLICY & REGULATION
  • Affordable Care Act
  • Federal Food, Drug, and Cosmetic Act
  • Antitrust and consumer protection controls
  • Drug and medical device lobbying
  • State and international life sciences legislation and regulation
  • ENFORCEMENT
  • Drug and medical device recalls
  • Drug safety actions
  • Pay-for-delay investigations
  • Merger reviews
  • LITIGATION
  • Patent disputes, including
  • Abbreviated New Drug Application litigation
  • Section 301 cases
  • Product safety suits over drugs and medical devices, including off-label marketing and failure-to-warn claims
  • Consumer litigation and class actions
  • Fraud and compliance suits
  • Antitrust disputes
  • Labor and employment suits
  • Shareholder and corporate governance disputes
  • Bankruptcy proceedings
  • TRANSACTIONS
  • Mergers, acquisitions, and joint ventures
  • Share buybacks and stock splits
  • Private equity deals
  • Patent-licensing agreements
  • PROFILES
  • Personnel moves
  • Profiles of life sciences practice groups

Readership

  • Life sciences lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Executives and attorneys in the drug, biotechnology, and medical device industries
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals